- Home
- ABBV vs TSM Comparison
ABBV vs TSM Comparison
Compare ABBV & TSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ABBV | TSM |
|---|---|---|
| Founded | 2012 | 1987 |
| Country | United States | Taiwan |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Semiconductors |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 451.5B | 2.3T |
| IPO Year | 2012 | 1998 |
Fundamental Metrics
Financial Performance| Metric | ABBV | TSM |
|---|---|---|
| Price | $276.95 | $441.55 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 30 | 21 |
| Target Price | $282.61 | ★ $578.22 |
| AVG Volume (30 Days) | 2.6M | ★ 7.5M |
| Earning Date | 10-30-2026 | 10-15-2026 |
| Dividend Yield | ★ 2.46% | 0.72% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 2.42 | N/A |
| Revenue | ★ $61,160,000,000.00 | N/A |
| Revenue This Year | $10.53 | $43.51 |
| Revenue Next Year | $8.80 | $35.90 |
| P/E Ratio | ★ $115.81 | $171.71 |
| Revenue Growth | ★ 8.57 | N/A |
| 52 Week Low | $190.75 | $266.82 |
| 52 Week High | $280.73 | $487.47 |
Technical Indicators
Market Signals| Indicator | ABBV | TSM |
|---|---|---|
| Relative Strength Index (RSI) | 66.93 | 46.86 |
| Support Level | $243.68 | $407.76 |
| Resistance Level | N/A | $447.23 |
| Average True Range (ATR) | 5.59 | 9.12 |
| MACD | 1.35 | -2.61 |
| Stochastic Oscillator | 74.56 | 7.01 |
Price Performance
Historical ComparisonAbout ABBV AbbVie Inc.
AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with Imbruvica and Venclexta). The company was spun off from Abbott in early 2013. The 2020 acquisition of Allergan added several new products and drugs in aesthetics, including Botox. The 2024 acquisitions of Cerevel (neuroscience) and ImmunoGen (oncology) help supplement AbbVie's portfolio.
About TSM Taiwan Semiconductor Manufacturing Company Ltd.
Taiwan Semiconductor Manufacturing Co. is the world's largest dedicated chip foundry, with about 70% market share in 2025. TSMC was founded in 1987 as a joint venture of Philips, the government of Taiwan, and private investors. It went public in Taiwan in 1994 and as an ADR in the US in 1997. TSMC's scale and high-quality technology allow the firm to generate solid operating margins, even in the highly competitive foundry business. Furthermore, the shift to the fabless business model has created tailwinds for TSMC. The foundry leader has an illustrious base of customers, including Apple, AMD, and Nvidia, that look to apply its cutting-edge process technologies to their semiconductor designs. TSMC employs more than 83,000 people.